| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/20/2008 | CN101244108A Application of isatis root and isatis root particle in medicament for preventing and controlling endotoxin endotoxemia |
| 08/20/2008 | CN101244095A New purpose of durio zibethinus L. shell extract |
| 08/20/2008 | CN101244077A Externally used Chinese medicine combination styptic powder and preparation thereof |
| 08/20/2008 | CN101244071A Method for preparing sodium fructose diphosphate injection |
| 08/20/2008 | CN101244060A Leonurus heterophyllus alkaloid composition and method of preparing the same |
| 08/20/2008 | CN101243870A Health food maintaining stable state normally of blood of human body |
| 08/20/2008 | CN101243865A Corn chips for nourishing hardiness |
| 08/20/2008 | CN101243819A Method for preparing Jupu tea |
| 08/20/2008 | CN101243814A Milk powder for the old and preparation thereof |
| 08/20/2008 | CN101243806A Pseudo-ginseng bread |
| 08/20/2008 | CN101243805A Health care biscuit |
| 08/20/2008 | CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/20/2008 | CN100412086C Glycopeptide compositions |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411659C Chinese medicine for treating aplastic anemia and preparation method thereof |
| 08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096722A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/14/2008 | WO2008096268A2 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery |
| 08/14/2008 | WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof |
| 08/14/2008 | WO2008076805A3 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/14/2008 | WO2008076805A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/14/2008 | US20080194681 Novel Inhibitors of Histone Deacetylase for the Treatment of Disease |
| 08/14/2008 | US20080194668 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-benzoic acid; 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-2-chloro-phenylamine; thrombocytopenia; radiation therapy, chemotherapy, immune therapy, cancers, viral infections, and transplants such as bone marrow and stem cell transplants |
| 08/14/2008 | US20080194654 Using monoamine oxidase inhibitor; prevention, therapy of gastrointestinal disorders; sexual disorders; antidepressants; cognition activators; analgesics |
| 08/14/2008 | US20080194643 Using pyrrolidonedicarboxamide compound; therapy for thrombosis, cardiovascular disorders; myocardoim infraction; restenosis; atherosclerosis; anticancer agents; sepsis; antidiabetic agents |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194590 Thrombosis therapy |
| 08/14/2008 | US20080194516 System for managing anti-coagulant infusions in patients |
| 08/14/2008 | US20080194501 Cyclic Bioisosters of Derivatives of a Purine System and Pharmaceutical Composition Based Thereon |
| 08/14/2008 | US20080194485 Use of a prolylcarboxypeptidase (PRCP) inhibitor to treat or prevent obesity; use for example t-butyl carbamate-prolyl prolinal (B-PP), N-benzyloxycarbonyl-prolyl-prolinal (Z-PP), diisopropyl fluorophosphate, PMSF, antipain, leupeptin, corn trypsin, and mercuric chloride |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194466 (5Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,4,6-Trichlorophenyl)Amino]-1,3-Thiazol-4(5H)-One |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193516 Oxygen-carrying blood substitute preparations |
| 08/14/2008 | US20080193466 Administering human antibody, or an antigen-binding fragment thereof, to subject, wherein antibody dissociates from human TNF alpha with a Kd of 1x10-8 M or less and a Koff rate constant of 1x10-3 s-1 or or less, and neutralizes human TNF alpha cytotoxicity with an IC50 of 1x10-7 M or less in L929 assay |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | CA2677657A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956082A1 Reversibly inactivated acidified plasmin |
| 08/13/2008 | EP1956081A1 Method for detection of human precursor t cell and precursor b cell |
| 08/13/2008 | EP1954696A2 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 08/13/2008 | EP1954677A1 Thiomorpholine compound and process for preparing the same |
| 08/13/2008 | EP1954251A1 Slow-release composition, method for the preparation thereof and use of the same |
| 08/13/2008 | EP1954136A2 Novel chemical compounds |
| 08/13/2008 | EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof |
| 08/13/2008 | EP1496905B1 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/13/2008 | EP1495030B1 Non-steroidal progesterone receptor modulators |
| 08/13/2008 | EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | CN101243070A Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 08/13/2008 | CN101243069A Thrombin inhibiting 2-oxo-1,2,5,6-tetrahydropyridine derivatives |
| 08/13/2008 | CN101242873A Food product and fortification system therefor |
| 08/13/2008 | CN101240263A TPO gene modifying human marrow stroma stem cell and its preparation method and use |
| 08/13/2008 | CN101240031A Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application |
| 08/13/2008 | CN101240030A Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240029A Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application |
| 08/13/2008 | CN101240028A Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240027A Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240026A Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine |
| 08/13/2008 | CN101240018A Peptides and related compounds having thrombopoietic activity |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239178A Antithrombotic use of peptide compounds |
| 08/13/2008 | CN101239166A Blood-regulating and face-nourishing capsule and preparation thereof |
| 08/13/2008 | CN101239152A Chinese herbal medicine oral liquid formulations aplastic anemia |
| 08/13/2008 | CN101239129A Method for preparing Chinese medicine with qi-benefitting and detoxication, blood seasis-dispersing and detumescence, and stomach-regulating and sedative function |
| 08/13/2008 | CN101239120A Yixueling tablet |
| 08/13/2008 | CN101239095A Method for preparing embolism-extinguishing enteric-coated capsule |
| 08/13/2008 | CN101239087A Active component for treating cardio-cerebrovascular disease and oral preparation thereof |
| 08/13/2008 | CN101239086A Active component for treating cardio-cerebrovascular disease and injection drug administration preparations thereof |
| 08/13/2008 | CN101239085A Method for extracting cockscomb total flavones |
| 08/13/2008 | CN101239075A Blood platelet aqueous products |
| 08/13/2008 | CN101239067A Medicinal composition |
| 08/13/2008 | CN101238896A High pressure swelling pork skin processing method |
| 08/13/2008 | CN101238845A Donkey-hide gelatin motherwort brown sugar |
| 08/13/2008 | CN100409890C Pharmaceutical composition for treating and preventing thrombus and its preparation method |
| 08/13/2008 | CN100409858C Composition of luffa seed oil |
| 08/12/2008 | US7411083 {[((1E)-{4-[3-(4-tert-butylphenoxy)prop-1-ynyl]phenyl}methylidene)amino]oxy}acetic acid; plasminogen activator inhibitor, anticoagulant; venous, arterial, cerebral, and deep vein thrombosis, atrial fibrillation, pulmonary fibrosis, myocardial ischemia, atherosclerotic plaque formation |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | CA2354845C Expression system for factor viii |
| 08/12/2008 | CA2217551C Photoactivated hypericin and the use thereof |
| 08/07/2008 | WO2008094617A2 Crystalline forms of deferasirox |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008069889A3 Methods of treating hemolytic anemia |
| 08/07/2008 | WO2008059029A3 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 08/07/2008 | WO2008054748A3 Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/07/2008 | WO2008034912A3 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof |
| 08/07/2008 | US20080188563 Blood fluidity improving agent |